Evidence map›Paper›PMID 34330348›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2021

Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens.

A G C Smith, M Gujabidze, T Avaliani, H M Blumberg, J M Collins, S Sabanadze, T Bakuradze, Z Avaliani, R R Kempker, M Kipiani

Open access · greenAbstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Management ofOpen forum infectious diseases · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Cycloserine and Linezolid for Tuberculosis Meningitis: Pharmacokinetic Evidence of Potential Usefulness.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

A G C SmithEmory University School of Medicine, Atlanta, GA, USA.
M GujabidzeNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
T AvalianiNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
H M BlumbergDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, Departments of Epidemiology and Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.
J M CollinsDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA.
S SabanadzeNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
T BakuradzeNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
Z AvalianiNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia.
R R KempkerDepartment of Medicine, Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA.
M KipianiNational Center for Tuberculosis and Lung Diseases, Tbilisi, Georgia, The University of Georgia, Tbilisi, Georgia.
National Center for Tuberculosis and Lung Disease · GEEmory University · USUniversity of Georgia · GE

Funding

Implementing a Maternal health and PRegnancy Outcomes Vision for Everyone (IMPROVE)UL1TR002378 · NCATS · EMORY UNIVERSITY · PI Andres J Garcia, Elizabeth O. Ofili · 2017 to 2026
$92.1M
J: NRSA Training CoreTL1TR002382 · NCATS · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Vasiliki Michopoulos · 2017 to 2026
$8.5M
Emory-Georgia TB Research Training ProgramD43TW007124 · FIC · EMORY UNIVERSITY · PI HENRY M BLUMBERG, Nestani Tukvadze · 2004 to 2026
$4.6M
High resolution plasma metabolomics to identify biomarkers of tuberculosisK23AI144040 · NIAID · EMORY UNIVERSITY · PI COLLINS, JEFFREY M · 2019 to 2023
$911k
An Exploratory Study of Anti-Tuberculosis Drug Penetration into Cerebrospinal FluidR03AI139871 · NIAID · EMORY UNIVERSITY · PI KEMPKER, RUSSELL RYAN · 2018 to 2019
$168k
FIC NIH HHS D43 TW007124NCATS NIH HHS TL1 TR002382NCATS NIH HHS UL1 TR002378NIAID NIH HHS K23 AI144040NIAID NIH HHS R03 AI139871
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Tuberculosis, MeningealAntitubercular AgentsFluoroquinolonesHumansLinezolidProspective StudiesAntitubercular AgentsFluoroquinolonesLinezolid

Identifiers

PMID34330348
PMCPMC8443977
OpenAlexW3185542371

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.